118 related articles for article (PubMed ID: 27839709)
1. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma.
Ezzat NE; Tahoun NS; Ismail YM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):229-234. PubMed ID: 27839709
[TBL] [Abstract][Full Text] [Related]
2. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
Levy M; Lin F; Xu H; Dhall D; Spaulding BO; Wang HL
Hum Pathol; 2010 Sep; 41(9):1210-9. PubMed ID: 20382408
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.
Ibrahim DA; Abouhashem NS
Pathol Res Pract; 2016 Apr; 212(4):288-93. PubMed ID: 26874572
[TBL] [Abstract][Full Text] [Related]
4. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma.
Sweeney J; Rao R; Margolskee E; Goyal A; Heymann JJ; Siddiqui MT
J Am Soc Cytopathol; 2018; 7(6):318-323. PubMed ID: 31043302
[TBL] [Abstract][Full Text] [Related]
6. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
[TBL] [Abstract][Full Text] [Related]
7. Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy.
Schmidt MT; Himmelfarb EA; Shafi H; Lin F; Xu H; Wang HL
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):478-87. PubMed ID: 22495381
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of S100p, IMP3, Maspin, and pVHL in the Differantial Diagnosis of Pancreatic Ductal Adenocarcinoma and Normal/chronic Pancreatitis in Fine Needle Aspiration Biopsy.
Aksoy-Altinboga A; Baglan T; Umudum H; Ceyhan K
J Cytol; 2018; 35(4):247-251. PubMed ID: 30498299
[TBL] [Abstract][Full Text] [Related]
9. Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.
Chiba M; Imazu H; Kato M; Ikeda K; Arakawa H; Kato T; Sumiyama K; Homma S
Oncol Rep; 2017 Apr; 37(4):1943-1952. PubMed ID: 28260012
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma.
Tadic M; Stoos-Veic T; Kujundzic M; Turcic P; Aralica G; Boskoski I
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):496-500. PubMed ID: 32109929
[TBL] [Abstract][Full Text] [Related]
11. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas.
Yantiss RK; Cosar E; Fischer AH
Acta Cytol; 2008; 52(2):133-8. PubMed ID: 18499984
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Lok T; Chen L; Lin F; Wang HL
Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma.
Kawashima H; Itoh A; Ohno E; Miyahara R; Ohmiya N; Tanaka T; Shimoyama Y; Nakamura S; Ebata T; Nagino M; Goto H; Hirooka Y
J Hepatobiliary Pancreat Sci; 2013 Apr; 20(4):441-7. PubMed ID: 23269460
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder.
Shi J; Liu H; Wang HL; Prichard JW; Lin F
Hum Pathol; 2013 Apr; 44(4):503-11. PubMed ID: 23079206
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-II mRNA-binding protein 3 expression in effusion cytology: a marker for metastatic adenocarcinoma cells and a potential prognostic indicator in gastric adenocarcinoma.
Kim HJ; Kim GE; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2014; 58(2):167-73. PubMed ID: 24457229
[TBL] [Abstract][Full Text] [Related]
18. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
19. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.
Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F
Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
